Clinical trials
Glaucoma, Open-Angle trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 17 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 11 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 7 |
| Glaukos Corporation | 6 |
| Cairo University | 4 |
| Chong Kun Dang Pharmaceutical | 3 |
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Aurolab | 2 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
| Kantonsspital Aarau | 2 |
| Military Institute od Medicine National Research Institute | 2 |
| National Eye Institute (NEI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma, Open-Angle | 110 |
| Glaucoma | 33 |
| Ocular Hypertension | 29 |
| Exfoliation Syndrome | 5 |
| Glaucoma, Angle-Closure | 5 |
| Low Tension Glaucoma | 5 |
| Cataract | 4 |
| Eye Diseases | 3 |
| Choroidal Effusions | 1 |
| Corneal Diseases | 1 |
Trials
Showing 26 to 50 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.